[Dopa and decarboxylase inhibitors in Parkinson's disease].
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Dopa og dekarboksylasehaemmere ved Parkinson's sygdom.